• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RHHBYN:MM

Price not available for RHHBYN:MM

Snapshot for Roche Holding AG (RHHBYN)

Open: - Day's Range: - Volume: 0
Previous Close: 450.86 52wk Range: - 1-Yr Rtn: -

Stock Chart for RHHBYN

No chart data available.
  • RHHBYN:MM 450.86
  • 1M
  • 1Y
450.86
Interactive RHHBYN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHHBYN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 15.9063
Relative P/E vs. MEXBOL -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 1.9830
Est. PEG Ratio 2.3547
Market Cap (M MXN) 3,355,387.58
Shares Outstanding (M) 5,620.50
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.24%
Cash Dividend (USD) 0.9151
Dividend Ex-Date 03/06/2014
5 Year Dividend Growth 12.68%
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHHBYN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHHBYN

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHHBYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil